Pinnacle Associates’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
156,004
-62,340
| -29% | -$569K | 0.02% | 445 |
|
|
2025
Q1 | $1.74M | Sell |
218,344
-1,854
| -0.8% | -$14.7K | 0.03% | 398 |
|
|
2024
Q4 | $1.2M | Buy |
220,198
+51,625
| +31% | +$280K | 0.02% | 457 |
|
|
2024
Q3 | $3.65M | Sell |
168,573
-124,678
| -43% | -$2.7M | 0.06% | 265 |
|
|
2024
Q2 | $3.18M | Buy |
293,251
+7,334
| +3% | +$79.6K | 0.05% | 293 |
|
|
2024
Q1 | $5.36M | Buy |
285,917
+117,344
| +70% | +$2.2M | 0.08% | 236 |
|
|
2023
Q4 | $3.65M | Sell |
168,573
-7,444
| -4% | -$161K | 0.06% | 268 |
|
|
2023
Q3 | $3.62M | Sell |
176,017
-5,971
| -3% | -$123K | 0.07% | 257 |
|
|
2023
Q2 | $8.56M | Sell |
181,988
-4,997
| -3% | -$235K | 0.15% | 166 |
|
|
2023
Q1 | $7.85M | Buy |
186,985
+15,204
| +9% | +$638K | 0.16% | 153 |
|
|
2022
Q4 | $6.55M | Buy |
171,781
+3,015
| +2% | +$115K | 0.14% | 173 |
|
|
2022
Q3 | $6.61M | Sell |
168,766
-5,632
| -3% | -$221K | 0.15% | 161 |
|
|
2022
Q2 | $5.63M | Sell |
174,398
-2,551
| -1% | -$82.4K | 0.12% | 193 |
|
|
2022
Q1 | $5.86M | Sell |
176,949
-1,943
| -1% | -$64.3K | 0.1% | 209 |
|
|
2021
Q4 | $7.61M | Buy |
178,892
+651
| +0.4% | +$27.7K | 0.13% | 173 |
|
|
2021
Q3 | $7.9M | Buy |
178,241
+100,268
| +129% | +$4.44M | 0.15% | 166 |
|
|
2021
Q2 | $4.43M | Buy |
77,973
+968
| +1% | +$55K | 0.08% | 231 |
|
|
2021
Q1 | $5.76M | Sell |
77,005
-7,680
| -9% | -$575K | 0.11% | 192 |
|
|
2020
Q4 | $7.33M | Sell |
84,685
-5,635
| -6% | -$487K | 0.15% | 154 |
|
|
2020
Q3 | $5.52M | Sell |
90,320
-3,740
| -4% | -$229K | 0.13% | 173 |
|
|
2020
Q2 | $3.91M | Buy |
+94,060
| New | +$3.91M | 0.1% | 205 |
|